Pharma Deals Review, Vol 2008, No 96 (2008)

Font Size:  Small  Medium  Large

Needle-free Vaccines Lead Intercell to the US with its Latest Acquisition

Sally Mardikian PhD

Abstract


Intercell has turned to the US to acquire Iomai - a company that will expand its travellers vaccine franchise and deliver novel transcutaneous immunization technology.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.